首页/数据集/Table S1 - XRCC3 Thr241Met Polymorphism and Clinical Outcomes of NSCLC Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis

Table S1 - XRCC3 Thr241Met Polymorphism and Clinical Outcomes of NSCLC Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis

Figshare2015-12-02 更新2026-04-29 收录

肿瘤遗传学

化疗疗效预测

数据链接：

https://figshare.com/articles/dataset/_XRCC3_Thr241Met_Polymorphism_and_Clinical_Outcomes_of_NSCLC_Patients_Receiving_Platinum_Based_Chemotherapy_A_Systematic_Review_and_Meta_Analysis_/764473 数据链接链接失效反馈

官方服务：

资源简介：

PRISMA checklist. (DOC)

应用场景：

创建时间：

2015-12-02

基因组扩增

肿瘤遗传学

The heterogeneity of tumor cells and their alteration during the course of the disease urges the need for real time characterization of individual tumor cells to improve the assessment of treatment op

NIAID Data Ecosystem90

Table2_Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients.XLSX

肿瘤遗传学

基因变异分析

Background: Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors arising from chromaffin cells in the adrenal medulla and extra-adrenal ganglia, respectively. The study was aimed t

NIAID Data Ecosystem50

Frequency distributions of haplotypes in 11q23.3 region among cases and controls, and their associations with glioma risk in a Chinese population.

肿瘤遗传学

疾病关联分析

Bold characters indicate corresponding P values are less than 6.67×10−4. aOrder of polymorphisms is rs12289253, rs3741324 in the block1; rs494560, rs17748 in the block2; rs10892251,rs11216943 in the b

NIAID Data Ecosystem30

Cdkn2a loss in a model of neurofibroma demonstrates stepwise tumor progression to atypical neurofibroma and MPNST

神经纤维瘤

肿瘤遗传学

Plexiform neurofibromas (PN) are benign nerve sheath Schwann cell tumors, common in patients with neurofibromatosis type 1 (NF1), that are characterized by biallelic mutations in the NF1 tumor suppres

干细胞与再生医学数据中心2022-02-20 更新90

DataSheet_1_Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.docx

化疗疗效预测

肿瘤免疫生物标志物

BackgroundBiomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this study was to evaluate the asso

NIAID Data Ecosystem50

Table S1 - XRCC3 Thr241Met Polymorphism and Clinical Outcomes of NSCLC Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis

资源简介：

相关数据集